Clinical Trials Browser

Phase 1 × Uveal Melanoma × Protein Subunit Vaccines × Clear all

NCT00471471 2017-06-22

Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Phase 1 Completed

Uveal Melanoma, Melanoma